News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
202 Results
Type
Article (2)
Press Release (200)
Section
Business (29)
Deals (5)
Drug Development (16)
News (52)
Policy (4)
Tag
Alliances (2)
Cardiovascular disease (1)
Cell therapy (4)
Clinical research (19)
COVID-19 (1)
C-suite (1)
Diagnostics (1)
Earnings (1)
Events (9)
Funding (4)
Healthcare (1)
Infectious disease (1)
IPO (7)
Manufacturing (1)
MASH (1)
Mergers & acquisitions (1)
Metabolic disorders (1)
People (32)
Phase 1 (4)
Phase 2 (13)
Regulatory (4)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (60)
2026 (3)
2025 (69)
2024 (13)
2023 (25)
2022 (32)
2021 (24)
2020 (3)
2019 (10)
2017 (4)
2016 (5)
2015 (14)
Location
Asia (1)
California (1)
Canada (50)
Europe (1)
Florida (2)
Minnesota (1)
New York (1)
Northern California (1)
Puerto Rico (1)
United States (6)
202 Results for "hemostemix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
Hemostemix Grants Stock Options
December 11, 2025
·
7 min read
Press Releases
Hemostemix Receives FDA Support for Its Basket Protocol Approach
January 16, 2026
·
8 min read
Press Releases
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
January 2, 2026
·
6 min read
Press Releases
Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)
Thomas Smeenk, BA, unveils a proposed conformal invariant, A = E/(hv), explored as a potential bridge between General Relativity, Quantum Mechanics, cosmology, and string theory.
December 11, 2025
·
9 min read
Press Releases
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
February 3, 2026
·
1 min read
Press Releases
Hemostemix Closes CDN$280,594 Private Placement
November 19, 2025
·
1 min read
Press Releases
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000
December 10, 2025
·
8 min read
Press Releases
Hemostemix Closes Private Placement of $461,230
November 4, 2025
·
8 min read
Press Releases
Hemostemix’s VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!
Florida SB 1768 Becomes Law: Hemostemix Inc. Begins Commercial Offering of ACP-01 (VesCell) for Ischemic Pain Treatments in Florida.
July 2, 2025
·
8 min read
1 of 21
Next
